Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic t cells and treat experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 5987-5996

  Burrows, Gregory G ^a,b,c   Bebo Jr , Bruce F ^a,b   Adlard, Kirsten L ^a   Vandenbark, Arthur A ^a,b   Offner, Halina ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENCEPHALITOGENIC PROTEIN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CROSS LINKING; DELAYED HYPERSENSITIVITY; DENATURATION; DNA SEQUENCE; ELECTROPHORESIS; ENCEPHALOMYELITIS; FLOW CYTOMETRY; LIQUID CHROMATOGRAPHY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FOLDING; RAT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0032402243     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Swanborg, R. H. 1983. Autoimmune effector cells. V. A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of auto-immune encephalomyelitis. J. Immunol. 130:1503.
2. Cush, J. J., and P. E. Lipsky. 1988. Phenoytpic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum. 31:1230.
3. Caspi, R. R., F. G. Roberge, C. C. Chan, B. Wiggert, G. J. Chader, L. A. Rozenszajn, Z. Lando, and R. B. Nussenblatt. 1988. A new model of autoimmune disease: experimental autoimmune uveorentinitis induced in mice with two different retinal antigens. J. Immunol. 140:1490.
4. Cobbold, S. P., J. A. Nash, T. D. Prospero, and H. Waldham. 1988. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
5. Steinman, L. 1993. Autoimmune disease. Sci. Am. 269:106.
6. Weinberg, A. D., J. J. Wallin, R. E. Jones, T. J. Sullivan, D. N. Boudette, A. A. Vandenbark, and H. Offner. 1994. Target organ specific upregulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152:4712.
7. Weinberg, A. D., R. Whitham, S. L. Swain, W. J. Morrison, G. Wyrick, C. Hoy, A. A. Vandenbark, and H. Offner. 1992. TGF-β enhances the in vivo effector function and memory phenotype of Ag-specific T helper cells in EAE. J. Immunol. 148:2109.
8. Quill, H., and R. H. Schwartz. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planer lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J. Immunol. 138:3704.
9. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1.
10. Stem, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 completed with an influenza virus peptide. Nature 368: 215.
11. Garboczi, D. N., D. T. Hung, D. C. and Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429.
12. 2 domain of HLA-DR molecules. Nature 356:799.
13. Huang, B., A. Yachou, S. Fleury, W. Hendrickson, and R. Sekaly. 1997. Analysis of the contact sites on the CD4 molecule with class II MHC molecule. J. Immunol. 158:216.
14. König, R., L. Y. Huang, and R. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356:796.
15. Fleury, S., D. Lamarre, S. Meloche, S. E. Ryu, C. Cantin, W. A. Hendrickson, and R. P. Sekaly 1991. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 66:1037.
16. Konig, R., X. Shen, and R. N. Germain. 1995. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.
17. Sharma, S. D., B. Nag, X. M. Su, D. Green, E. Spack, B. R. Clark, and S. Sriram. 1991. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc. Natl. Acad. Sci. USA 88:11465.
18. Kozono, H., J. White, J. Clements, P. Marrack, and J. Kappler. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151.
19. Nag, B., S. Arimilli, P. V. Mukku, and I. Astafieva. 1996. Functionally active recombinant α and β chain-peptide complexes of human major histocompatibility class II molecules. J. Biol. Chem. 271:10413.
20. Nag, B., H. G. Wada, S. V. Deshpande, D. Passmore, T. Kendrick, S. D. Sharma, B. R. Clark, and H. M. McConnell. 1993. Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90:1604.
21. Arimilli, S., C. Cardoso, P. Mukku, V. Baichwal, and B. Nag. 1995. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant α and β polypeptide chains. J. Biol. Chem. 270:971.
22. Rhode, P. R., M. Burkhardt, J. Jiao, A. H. Siddiqui, G. P. Huang, and H. C. Wong. 1996. Single-chain MHC class II molecules induce T cell activation and apoptosis. J. Immunol. 157:4885.
23. Matsui, K., J. J. Boniface, P. A. Reay, H. Schild, B. Fazekas de St. Groth, and M. M. Davis. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788.
24. Nag, B., D. Passmore, T. Kendrick, H. Bhayani, and S. D. Sharma. 1992. N-linked oligosaccharides of murine major histocompatibility complex class II molecule: role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness. J. Biol. Chem. 267:22624.
25. Nicolle, M. W., B. Nag, S. D. Sharma, N. Willcox, A. Vincent, D. J. Ferguson, and J. Newsom-Davis. 1994. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J. Clin. Invest. 93: 1361.
26. Nag, B., S. V. Deshpande, S. D. Sharma, and B. R. Clark. 1993. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen. J. Biol. Chem. 268:14360.
27. Spack, E. G., M. McCutcheon, N. Corbelletta, B. Nag, D. Passmore, and S. D. Sharma. 1995. Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II:acetylcholine receptor complexes. J. Autoimmun. 8:787.
28. Paterson, P. Y. 1981. Multiple sclerosis: an immunologic reassessment. J. Chronic. Dis. 26:119.
29. Weiner, H. L., G. A. Mackin, M. Matsui, E. J. Orav, S. J. Khoury, D. M. Dawson, and D. A. Hafler. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in MS. Science 259:1321.
30. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541.
31. Howell, M. D., S. T. Winters, T. Olee, H. C. Powell, D. J. Carlo, and S. W. Brostoff. 1989. Vaccination against experimental allergic encephalomyelilis with T-cell receptor peptides. Science 246:668.
32. Oksenberg, J. R., M. A. Panzara, A. B. Begovich, D. Mitchell, H. A. Erlich, R. S. Murray, R. Shimonkevitz, M. Sherritt, J. Rothbard, C. C. Bernard, et al. 1993. Selection of T-cell receptor V-D-J gene rearrangements with specificity for a MBP peptide in brain lesions of MS. Nature 362:68.
33. Yednock, T. A., C. Cannon, L. C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4/β1 integrin. Nature 356:63.
34. Jameson, B. A., J. M. McDonnel, J. C. Marini, and R. Korngold. 1994. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744.
35. Vandenbark, A. A., M. Vainiene, B. Celnik, G. A. Hashim, A. C. Buenafe, and H. Offner. 1994. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP peptides. J. Immunol. 15:852.
36. Bourdette, D. N., M. Vainiene, W. Morrison, R. Jones, M. J. Turner, G. A. Hashim, A. A. Vandenbark, and H. Offner. 1991. Myelin basic protein specific T cells in the CNS and lymph nodes of rats with EAE are different. J. Neurosci. Res. 30:308.
37. Derman, A. I., W. A. Prinz, D. Belin, and J. Beckwith. 1993. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science 262:1744.
38. Syha, J., W. Henkes, and K. Reske. 1989. Complete cDNA sequence coding for the MHC class II RTI.B α-chain of the Lewis rat. Nucleic Acids Res. 17:3985.
39. Syha-Jedelhauser, J., U. Wendling, and K. Reske. 1991. Complete coding nucleotide sequence of cDNA for the Class II RTI.B β-chain of the Lewis rat. Biochim. Biophys. Acta 1089:414.
40. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60.
41. King, J., and U. K. Leimmli. 1973. Bacteriophage T4 tail assembly: structural proteins and their genetic identification. J. Mol. Biol. 75:315.
42. Thompson, D., and G. Larson. 1992. Western blots using stained protein gels. Biotechniques 12:656.
43. Wegmann, K. W., W. Zhao, A. C. Griffin, and W. F. Hickey. 1994. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. J. Immunol. 153:892.
44. Hashim, G. A., E. D. Day, L. Fredane, P. Intintola, and E. Carvalho. 1986. Biological activity of region 65 to 102 of the myelin basic protein. J. Neurosci. Res. 16:467.
45. Martenson, R. E. 1984. Myelin basic protein speciation. In Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. Alan R. Liss, Inc., New York, p. 511.
46. Vandenbark, A. A., T. Gill, and H. Offner. 1985. A myelin basic protein specific T lymphocyte line which mediates EAE. J. Immunol. 135:223.
47. k peptide motif revealed by sequencing naturally processed peptides from T cell hybridoma class I molecules. J. Neurosci. Res. 45:803.
48. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822.
49. Gold, D. P., H. Offner, D. Sun, S. Wiley, A. A. Vandenbark, and D. B. Wilson. 1991. Analysis of T cell receptor βchains in Lewis rats with experimental autoimmune encephalomyelitis: conserved complementarity determining region 3. J. Exp. Med. 174:1467.
50. Golding, H., J. McCluskey, T. I. Munitz, R. N. Germain, D. H. Margulies, and A. Singer. 1985. T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4. Nature 317:425.
51. Bourdette, D. N., M. Vainiene, W. Morrison, R. Jones, M. J. Turner, G. A. Hashim, A. A. Vandenbark, and H. Offner. 1991. Myelin basic protein specific T cells in the CNS and lymph nodes of rats with EAE are different. J. Neurosci. Res. 30:308.
52. Ferrin, T. E., C. C. Huang, L. E. Jarvis, and R. Langridge. 1988. The MIDAS display system. J. Mol. Graphics 6:13.
53. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, and J. L. Strominger. 1993. Three dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
54. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
55. Zhao, B., M. Carson, S. E. Ealick, and C. E. Bugg. 1992. Structure of scorpion toxin variant-3 at 1.2 angstroms resolution. J. Mol. Biol. 227:239.
56. Housset, D., C. Habersetzer-Rochat, J. P. Astier, and J. C. Fontecilla-Camps. 1994. Crystal structure of toxin II from the scorpion Androctonus Australis Hector refined at 1.3 angstroms resolution. J. Mol. Biol. 238:88.
57. Zinn-Justin, S., M. Guenneugues, C. Drakopoulou, B. Gilquin, C. Vita, and A. Menez. Transfer of a β-hairpin from the functional site of snake curaremimetic toxins to the α/β scaffold of scorpion toxins: three-dimensional solution structure of the chimeric protein. Biochemistry 35:8538.
58. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321.
59. Burrows, G. G., K. Ariail, B. Celnik, J. E. Gambee, H. Offner, and A. A. Vandenbark. 1997. Multiple class I motifs revealed by sequencing naturally processed peptides eluted from rat T cell MHC molecules. J. Neurosci. Res. 49:107.
60. McHeyzer, M. G., and M. M. Davis. 1995. Antigen specific development of primary and memory T cells in vivo. Science 268:106.
61. MacDonald, H. R., J. L. Casanova, J. L. Maryanski, and J. C. Cerottini. 1993. Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction. J. Exp. Med. 177:1487.
62. Walker, P. R., T. Ohteki, J. A. Lopez, H. R. MacDonald, and J. L. Maryanski. 1995. Distinct phenotypes of antigen-selected CDS T cells emerge at different stages of an in vivo immune response. J. Immunol. 155:3443.
63. Reiner, S. L., Z. E. Wang, F. Hatam, P. Scott, and R. M. Locksley. 1993. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science 259: 1457.
64. Corr, M., A. E. Slanetz, L. F. Boyd, M. T. Jelonek, S. Knilko, B. K. al-Ramadi, Y. S. Kim, S. E. Maher, A. L. Bothwell, and D. H. Margulies. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265:946.
65. K complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA 91:12862.
66. Sykulev, Y., A. Brunmark, M. Jackson, R. J. Cohen, P. A. Peterson, and H. N. Eisen. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15.
67. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. MeHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
68. Nag, B., T. Kendrick, S. Arimilli, S. C. Yu, and S. Sriram, S. 1996. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells. Cell. Immunol. 170:25.
69. Desbarats, J., J. H. Freed, P. A. Campbell, and M. K. Newell. 1996. Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells. Proc. Natl. Acad. Sci. USA 91:11014.
70. Moebius, U., P. Pallai, S. C. Harrison, and E. L. Reinherz. 1993. Delineation of an extended surface contact area on human CD4 involved in class II MHC binding. Proc. Natl. Acad. Sci. USA 90:8259.
71. Konig, R., X. Shen, and R. N. Germain. 1995. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.
72. lck. Cell 55:301.
73. Govaerts, A., J. Gony, C. Martin-Mondiere, J. C. Poirier, M. Schmid, E. Schuller, J. D. Degos, and J. Dausset. 1985. HLA and multiple sclerosis: population and family studies. Tissue Antigens 25:187.
74. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
75. Vandenbark, A. A., B. Celnik, M. Vainiene, S. D. Miller, and H. Offner. 1995. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. J. Immunol. 155:5861.